...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
Reply New Message
Back To Forum List View
Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
3
narmac
Jan 29, 2019 07:42PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
4
Nextblockbuster
Jan 30, 2019 07:36AM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
3
tada
Jan 30, 2019 10:04AM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
5
Nextblockbuster
Jan 30, 2019 10:14AM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
5
KayakerBC
Jan 30, 2019 12:14PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
5
imtesty
Feb 01, 2019 08:55PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
6
tada
Feb 03, 2019 04:01AM

FYI  -  Zenith tells me they will be issuing an updated FMV letter by end of this week!

2 Recommendations
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
3
Toinv
Feb 08, 2019 03:26PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
3
Toinv
Feb 09, 2019 02:45PM
Icon president Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
1
BearDownAZ
Feb 10, 2019 10:07PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
2
Toinv
Feb 11, 2019 01:27PM
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
2
tada
Feb 11, 2019 10:41PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply